Clinical Trial Update: Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use [NA]

View source ↗

Summary

A clinical trial evaluating remotely delivered programs to address COVID-19-related stress, depression, and substance use has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder
• Substance Use Disorders

Snippet

Sponsor: Cambridge Health Alliance | Conditions: Depression, Anxiety | NA | Status: COMPLETED